Cardiac Biotech Solutions Statistics
Total Valuation
CBSC has a market cap or net worth of 7.22 million.
| Market Cap | 7.22M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CBSC has 164.02 million shares outstanding.
| Current Share Class | 164.02M |
| Shares Outstanding | 164.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 143.28 |
| PB Ratio | -5.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 54.21% |
| Revenue Per Employee | 10,074 |
| Profits Per Employee | -128,109 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.33% in the last 52 weeks. The beta is 1.15, so CBSC's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -28.33% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 48.35 |
| Average Volume (20 Days) | 13,171 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.15 |
Income Statement
In the last 12 months, CBSC had revenue of 50,370 and -640,547 in losses. Loss per share was -0.01.
| Revenue | 50,370 |
| Gross Profit | 27,373 |
| Operating Income | -748,497 |
| Pretax Income | -640,547 |
| Net Income | -640,547 |
| EBITDA | n/a |
| EBIT | -748,497 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 6,820 in cash and n/a in debt, giving a net cash position of 6,820 or 0.00 per share.
| Cash & Cash Equivalents | 6,820 |
| Total Debt | n/a |
| Net Cash | 6,820 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -1.38M |
| Book Value Per Share | -0.02 |
| Working Capital | -1.40M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 54.34% |
| Operating Margin | -1,486.00% |
| Pretax Margin | -1,271.68% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CBSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -8.88% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 16, 2016. It was a reverse split with a ratio of 0.0133333.
| Last Split Date | Feb 16, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.0133333 |
Scores
CBSC has an Altman Z-Score of -100.66. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -100.66 |
| Piotroski F-Score | n/a |